Article Information
History
- August 1, 2020.
Article Versions
- Version 1 (July 24, 2020 - 20:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Christian Arias-Reyes1,
- Favio Carvajal-Rodriguez1,
- Liliana Poma-Machicao1,
- Fernanda Aliaga-Raudan1,
- Danuzia A. Marques1,
- Natalia Zubieta DeUrioste2,
- Roberto Alfonso Accinelli5,
- Edith M. Schneider-Gasser4,
- Gustavo Zubieta-Calleja2,
- Mathias Dutschmann3 and
- Jorge Soliz1,2,*
- 1Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada
- 2High Altitude Pulmonary and Pathology Institute IPPA. La Paz, Bolivia
- 3Florey Institute of Neuroscience and Mental Health, Gate 11 Royal Parade, 3052 University of Melbourne Victoria, Australia
- 4Institute of Veterinary Physiology, Vetsuisse-Faculty University of Zurich Winterthurerstrasse 260, Zurich, Switzerland
- 5Instituto de Investigaciones de la Altura. Universidad Peruana Cayetano Heredia, Lima, Perú
- ↵*Corresponding author:
Jorge Soliz, PhD, Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), 2725, chemin Sainte-Foy, Québec, QC Canada G1V 4G5, Associate researcher at the High Altitude Pulmonary and Pathology Institute IPPA, E-mail: jorge.soliz{at}crchuq.ulaval.ca, Tél.: 418-656-8711, Fax: 418-656-4929
Posted August 01, 2020.
Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent
